Celldex Therapeutics
CLDX
$36.26
Share price
-2.05%
Change (1 day)
6.71%
Change (1 year)
Categories
Market capitalization of Celldex Therapeutics (CLDX)
Market cap: $2.43 Billion
As of April 2024 Celldex Therapeutics has a market cap of $2.43 Billion. This makes Celldex Therapeutics the world's 3775th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Celldex Therapeutics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.43 B | 12.13% |
| 2023 | $2.16 B | 3.32% |
| 2022 | $2.09 B | 16.26% |
| 2021 | $1.80 B | 160.23% |
| 2020 | $0.69 B | 1733.29% |
| 2019 | $37.84 M | 6.63% |
| 2018 | $35.49 M | -90.81% |
| 2017 | $0.38 B | 7.75% |
| 2016 | $0.35 B | -76.84% |
| 2015 | $1.54 B | -5.36% |
| 2014 | $1.63 B | -24.33% |
| 2013 | $2.16 B | 400.33% |
| 2012 | $0.43 B | 276.23% |
| 2011 | $0.11 B | -13.09% |
| 2010 | $0.13 B | -10.75% |
| 2009 | $0.14 B | 18.32% |
| 2008 | $0.12 B | 237.13% |
| 2007 | $37.09 M | -62.96% |
| 2006 | $0.10 B | -28.18% |
| 2005 | $0.13 B | -6.42% |
| 2004 | $0.14 B | -15.96% |
| 2003 | $0.17 B | 158.92% |
| 2002 | $68.47 M | -71.75% |
| 2001 | $0.24 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Celldex Therapeutics was reported to be:
$2.43 Billion
$2.38 Billion
$2.02 Billion
$2.02 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $148.75 B | 6,016.15% | 🇺🇸 USA |
 Amgen AMGN | $146.43 B | 5,920.80% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.58 B | 3,336.46% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $6.4 M | -99.74% | 🇺🇸 USA |
 Seagen
SGEN | $43.15 B | 1,674.34% | 🇺🇸 USA |
 Agenus
AGEN | $0.17 B | -92.85% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.10 B | -95.80% | 🇺🇸 USA |